TRPC1 and atherosclerosis: In VSMCs, TRPC1-based SOCs mediate Ca2+ entry pathways which contribute to contractility, proliferation, and migration, and are potential therapeutic targets for cardiovascular diseases such as hypertension and atherosclerosis.1-3